Related Articles
COMPARISON OF RESPONSE TO 5'-DEOXY-5-FLUOROURIDINE THERAPY ALONE AND IN COMBINATION WITH TAMOXIFEN OR MEDROXYPROGESTERONE ACETATE IN ADVANCED AND RECURRENT BREAST-CANCER
ANTITUMOR EFFECT OF MEDROXYPROGESTERONE ACETATE (MPA) ON 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY-CARCINOMA DEPENDS UPON THE MPA CONCENTRATION IN TUMORS OF RATS
Relationship between expression of plasminogen activator system and metastatic ability in human cancers
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: An EORTC Receptor and Biomarker Group collaboration
Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients.